Volume 149, Issue 1, Pages (July 2015)

Slides:

Advertisements

Similar presentations

Raseen Tariq, MBBS, Renee M. Weatherly, Patricia P

Advertisements

Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Lauren M. De Leon, James B.

Gastrointestinal Stromal Tumors: Disease and Treatment Update

Complications of Proton Pump Inhibitor Therapy

Volume 152, Issue 4, Pages (March 2017)

Genetics and Genomics in the Practice of Medicine

Outcomes Among Living Liver Donors

Microbiome at the Frontier of Personalized Medicine

David L. McCollum, J. Martin Rodriguez

Ira J. Fox, Stephen C. Strom Gastroenterology

Gastroenterology 2011–2016: Looking Back and Forward

Making Sense of HDAC2 Mutations in Colon Cancer

Maged K. Rizk, James Merlino, Ashish Atreja

Biliary Obstruction From a Bile Duct Mass

Microbiome at the Frontier of Personalized Medicine

Clinical Challenges and Images in GI

The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?

Unusual Case of an Upset Stomach

Volume 135, Issue 4, Pages (October 2008)

An Unusual Post Gastrectomy Complication

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Volume 150, Issue 4, Pages (April 2016)

Yutaka Tomizawa, Lei Zhao, Leslie W. Yang Gastroenterology

Jean-Michel Pawlotsky Gastroenterology

Our New President—John I. Allen, MD, MBA, AGAF

Probiotics in Perspective

Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health?

Update on the Use of Vonoprazan: A Competitive Acid Blocker

Volume 145, Issue 1, Pages (July 2013)

Colon Cancer: An Update and Future Directions

Therapeutic Potential of Fecal Microbiota Transplantation

Volume 145, Issue 1, Pages (July 2013)

Gastrointestinal Stromal Tumors: Disease and Treatment Update

Treatment of Hypohepatia After Transplantation of Liver From a Living Donor Liver by Transcatheter Embolization, Using a Simulated 3-Dimensional Printing.

Volume 148, Issue 5, Pages (May 2015)

Clinical Challenges and Images in GI

Volume 149, Issue 1, Pages (July 2015)

A Common Disease With an Unusual Complication of Acute Abdomen

Coffee and Colorectal Cancer: Grounds for Prevention?

Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients Elena M. Stoffel, Anu Chittenden

Volume 133, Issue 2, Pages (August 2007)

Volume 149, Issue 1, Pages e6 (July 2015)

Recurrent Hematochezia in a Patient With Chronic Constipation

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Volume 148, Issue 3, Pages (March 2015)

Covering the Cover Gastroenterology

Shivan J. Mehta, Kimberly A. Forde Gastroenterology

Microscopic Colitis Gastroenterology

Volume 150, Issue 7, Pages (June 2016)

The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures

Covering the Cover Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Richard Blumberg, Judy Cho, James Lewis, Gary Wu Gastroenterology

Volume 147, Issue 4, Pages (October 2014)

Volume 156, Issue 4, Pages (March 2019)

Volume 156, Issue 5, Pages e3 (April 2019)

Volume 139, Issue 1, Pages (July 2010)

Changing of the Guards: 2011–2016 Gastroenterology Team

A “Crescent-in-doughnut” Lesion at Right Lower Quadrant Abdomen

How Does a Gastroenterologist Demonstrate Value?

Volume 155, Issue 6, Pages (December 2018)

Volume 139, Issue 6, Pages e1 (December 2010)

Cancer Costs Projected to Reach at Least $158 Billion in 2020

Volume 138, Issue 6, Pages (May 2010)

Reinvesting in US Biomedical Research—The Time is Now

Our New President—Anil K. Rustgi, MD

Electronic Clinical Challenges and Images in GI

The Future of Endoscopic Retrograde Cholangiopancreatography

Controversies in Liver Transplantation for Hepatitis C

Covering the Cover Gastroenterology

Presentation transcript:

Volume 149, Issue 1, Pages 223-237 (July 2015) Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook Colleen R. Kelly, Stacy Kahn, Purna Kashyap, Loren Laine, David Rubin, Ashish Atreja, Thomas Moore, Gary Wu Gastroenterology Volume 149, Issue 1, Pages 223-237 (July 2015) DOI: 10.1053/j.gastro.2015.05.008 Copyright © 2015 AGA Institute Terms and Conditions

Figure 1 Mechanisms underlying successful treatment of recurrent CDI with FMT. Improvement in symptoms after FMT has been associated with changes in microbial community structure, such as a decrease in Proteobacteria as well as restoration of microbial diversity, increase in secondary bile acid production, and niche exclusion by other bacteria. Used with permission of Mayo Foundation for Medical Education and Research, all rights reserved. Gastroenterology 2015 149, 223-237DOI: (10.1053/j.gastro.2015.05.008) Copyright © 2015 AGA Institute Terms and Conditions